COVID and Lung Cancer

por Calabrò, Luana, Rossi, Giulia, Covre, Alessia, Morra, Aldo, Maio, Michele
Publicado 2021

A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation

por Maio, Michele, Lahn, Michael, Di Giacomo, Anna Maria, Covre, Alessia, Calabrò, Luana, Ibrahim, Ramy, Fox, Bernard
Publicado 2021

Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies

por Sigalotti, Luca, Covre, Alessia, Fratta, Elisabetta, Parisi, Giulia, Colizzi, Francesca, Rizzo, Aurora, Danielli, Riccardo, Nicolay, Hugues JM, Coral, Sandra, Maio, Michele
Publicado 2010

Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients

por Sigalotti, Luca, Fratta, Elisabetta, Bidoli, Ettore, Covre, Alessia, Parisi, Giulia, Colizzi, Francesca, Coral, Sandra, Massarut, Samuele, Kirkwood, John M, Maio, Michele
Publicado 2011

Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients

por Sigalotti, Luca, Covre, Alessia, Fratta, Elisabetta, Parisi, Giulia, Sonego, Paolo, Colizzi, Francesca, Coral, Sandra, Massarut, Samuele, Kirkwood, John M, Maio, Michele
Publicado 2012

Immunotherapy of brain metastases: breaking a “dogma”

por Di Giacomo, Anna Maria, Valente, Monica, Cerase, Alfonso, Lofiego, Maria Fortunata, Piazzini, Francesca, Calabrò, Luana, Gambale, Elisabetta, Covre, Alessia, Maio, Michele
Publicado 2019

The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma

por Montico, Barbara, Giurato, Giorgio, Pecoraro, Giovanni, Salvati, Annamaria, Covre, Alessia, Colizzi, Francesca, Steffan, Agostino, Weisz, Alessandro, Maio, Michele, Sigalotti, Luca, Fratta, Elisabetta
Publicado 2021

Immunomodulatory activity of SGI-110: a basis for novel chemo-immunotherapeutic combinations in cancer treatment

por Covre, Alessia, Parisi, Giulia, Nicolay, Hugues JMG, Fazio, Carolina, Fonsatti, Ester, Fratta, Elisabetta, Sigalotti, Luca, Taverna, Pietro, Choy, Gavin, Azab, Mohammad, Coral, Sandra, Maio, Michele
Publicado 2013

Challenges in lung cancer therapy during the COVID-19 pandemic

por Calabrò, Luana, Peters, Solange, Soria, Jean-Charles, Di Giacomo, Anna Maria, Barlesi, Fabrice, Covre, Alessia, Altomonte, Maresa, Vegni, Virginia, Gridelli, Cesare, Reck, Martin, Rizvi, Naiyer, Maio, Michele
Publicado 2020

Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy

por Lofiego, Maria Fortunata, Cannito, Sara, Fazio, Carolina, Piazzini, Francesca, Cutaia, Ornella, Solmonese, Laura, Marzani, Francesco, Chiarucci, Carla, Di Giacomo, Anna Maria, Calabrò, Luana, Coral, Sandra, Maio, Michele, Covre, Alessia
Publicado 2021

Loss of Spry1 reduces growth of BRAF(V600)-mutant cutaneous melanoma and improves response to targeted therapy

por Montico, Barbara, Colizzi, Francesca, Giurato, Giorgio, Rizzo, Aurora, Salvati, Annamaria, Baboci, Lorena, Benedetti, Dania, Pivetta, Eliana, Covre, Alessia, Bo, Michele Dal, Weisz, Alessandro, Steffan, Agostino, Maio, Michele, Sigalotti, Luca, Fratta, Elisabetta
Publicado 2020

Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 study

por Calabrò, Luana, Rossi, Giulia, Morra, Aldo, Rosati, Claudio, Cutaia, Ornella, Daffinà, Maria Grazia, Altomonte, Maresa, Di Giacomo, Anna Maria, Casula, Milena, Fazio, Carolina, Palmieri, Giuseppe, Giannarelli, Diana, Covre, Alessia, Maio, Michele
Publicado 2021

Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy

por Fazio, Carolina, Covre, Alessia, Cutaia, Ornella, Lofiego, Maria Fortunata, Tunici, Patrizia, Chiarucci, Carla, Cannito, Sara, Giacobini, Gianluca, Lowder, James N., Ferraldeschi, Roberta, Taverna, Pietro, Di Giacomo, Anna Maria, Coral, Sandra, Maio, Michele
Publicado 2018

Circulating Levels of PD-L1 in Mesothelioma Patients from the NIBIT-MESO-1 Study: Correlation with Survival

por Chiarucci, Carla, Cannito, Sara, Daffinà, Maria Grazia, Amato, Giovanni, Giacobini, Gianluca, Cutaia, Ornella, Lofiego, Maria Fortunata, Fazio, Carolina, Giannarelli, Diana, Danielli, Riccardo, Di Giacomo, Anna Maria, Coral, Sandra, Calabrò, Luana, Maio, Michele, Covre, Alessia
Publicado 2020

A novel microRNA signature for the detection of melanoma by liquid biopsy

por Sabato, Claudia, Noviello, Teresa Maria Rosaria, Covre, Alessia, Coral, Sandra, Caruso, Francesca Pia, Besharat, Zein Mersini, Splendiani, Elena, Masuelli, Laura, Battistelli, Cecilia, Vacca, Alessandra, Catanzaro, Giuseppina, Po, Agnese, Anichini, Andrea, Maio, Michele, Ceccarelli, Michele, Di Giacomo, Anna Maria, Ferretti, Elisabetta
Publicado 2022

Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial

por Noviello, Teresa Maria Rosaria, Di Giacomo, Anna Maria, Caruso, Francesca Pia, Covre, Alessia, Mortarini, Roberta, Scala, Giovanni, Costa, Maria Claudia, Coral, Sandra, Fridman, Wolf H., Sautès-Fridman, Catherine, Brich, Silvia, Pruneri, Giancarlo, Simonetti, Elena, Lofiego, Maria Fortunata, Tufano, Rossella, Bedognetti, Davide, Anichini, Andrea, Maio, Michele, Ceccarelli, Michele
Publicado 2023

Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy

por Anichini, Andrea, Molla, Alessandra, Nicolini, Gabriella, Perotti, Valentina Eleonora, Sgambelluri, Francesco, Covre, Alessia, Fazio, Carolina, Lofiego, Maria Fortunata, Di Giacomo, Anna Maria, Coral, Sandra, Manca, Antonella, Sini, Maria Cristina, Pisano, Marina, Noviello, Teresa, Caruso, Francesca, Brich, Silvia, Pruneri, Giancarlo, Maurichi, Andrea, Santinami, Mario, Ceccarelli, Michele, Palmieri, Giuseppe, Maio, Michele, Mortarini, Roberta
Publicado 2022